Hepasig
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hepasig, covering 2016-12-15 to 2016-12-15. Get the full timeline:
Most recent: Clinical Trial Update: The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients [Phase 1]